NL-OMON51787尚未招募不适用
Influence of JAK inhibitors on the disease-associated network of intestinal immune cells in ulcerative colitis - JAK inhibition in ulcerative colitis
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •ulcerative colitis
- •indication for JAK inhibitor
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Effects of JAK inhibition on rheumatoid arthritis-related comorbidities: link between bone and vascular effects(investigator-initiated grant proposal)Rheumatoid ArthritisEUCTR2015-002523-26-HUArthritis Alapítvány
招募中
4 期
Investigating the role of JAK inhibition in achieving and maintaining disease remission in psoriatic arthritis (PsA).Psoriatic Arthritis2024-511401-40-00UZ Leuven20
进行中（未招募）
1 期
Investigating the role of JAK inhibition in achieving and maintaining disease remission in psoriatic arthritis (PsA).MedDRA version: 21.0Level: LLTClassification code: 10037160Term: Psoriatic arthritis Class: 10028395Psoriatic ArthritisCTIS2024-511401-40-00Z Leuven20
进行中（未招募）
不适用
A Randomized Study of the JAK Inhibitor INCB018424 Tablets Compared to Best Available Therapy in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) - COMFORT IIMedDRA version: 12.0Level: LLTClassification code 10028537Term: MyelofibrosisMyelofibrosisEUCTR2009-009858-24-ITIncyte Corporation150
Unknown
3 期
Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to MethotrexateRheumatoid ArthritisJAK InhibitorIL-6 InhibitorMusculoskeletal UltrasoundBiomarkerNCT05090410Atsushi Kawakami400